DNA Repair Drugs Market Connected with Market Growth fueled by Rising Prevalence of Cancer


DNA Repair Drugs Market 


Market Overview:

DNA repair drugs play a vital role in repairing damaged DNA during cancer treatment. They repair damaged DNA caused by radiation or chemotherapy treatment and help target and destroy cancer cells more effectively with reduced side effects. DNA repair drugs aid in repair of single and double strand DNA breaks that occur during cancer treatment to enhance efficacy of radiation and chemotherapy.


Market key trends:
One of the key factors driving growth of the DNA repair drugs market is increasing prevalence of cancer worldwide. According to the World Health Organization (WHO), cancer burden rose to 18.1 million new cases and 9.6 million deaths in 2018 globally. Improper DNA repair of radiation and chemotherapy treatment induced DNA damage in cancer cells leads to recurrence of cancer. DNA repair drugs helps repair these damages in DNA aiding longer remission duration and improved survival rates. They promote restoration of DNA integrity and cellular repair capacity enabling safe and efficient administration of higher curative radiation and chemotherapy doses for better treatment outcomes.

Market Dynamics:
The DNA Repair Drugs Market Growth is witnessing high growth owing to the rising prevalence of various types of cancer globally. According to the World Health Organization, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. The increasing research and development activities in the area of DNA damage repair pathways have led to a rise in the pipeline drugs for different cancer types. Further, the approval and launch of new DNA repair drugs to treat cancer is also boosting the market growth. For instance, in January 2022, the U.S FDA granted accelerated approval to Repare Therapeutics' HER2-directed DNA repair inhibitor camonsertib for recurrent or metastatic HER2-positive breast cancer patients.


SWOT Analysis

Strength: DNA repair drugs have shown promising results in clinical trials. The repair mechanisms have broad applications across several cancer types. Researchers are continuously working to develop newer targeted molecules.

Weakness: DNA repair is a complex process involving multiple pathways. Targeting specific defects requires thorough understanding of the underlying biology. High costs are involved in drug development and clinical trials.

Opportunity: With advancing research, more cancer driver mutations are being identified. This will expand the scope of personalized targeted therapies. Collaboration between pharmaceutical companies and research institutes can help expedite the drug development process.

Threats: Competing drug classes like immunotherapies are becoming popular treatment options. Financial pressure during drug development may lead to project delays or discontinuation. Stringent regulations surrounding clinical trials also pose challenges.


Key Takeaways

The global DNA repair drugs market is expected to witness high growth, exhibiting CAGR of 32.4% over the forecast period, due to increasing incidence of cancer worldwide. Targeted drugs that inhibit specific DNA repair pathways have shown promising results with improved efficacy and lesser side effects compared to traditional chemotherapy.

Regional analysis
North America currently dominates the global market due to advanced research facilities and increasing adoption of personalized medicines in the region. However, Asia Pacific is expected to grow at a high CAGR during the forecast period due to rising healthcare spending, growing cancer burden and expanding pharmaceutical industry in the region.

Key players
Key players operating in the DNA repair drugs market are AstraZeneca Plc., Johnson & Johnson, GlaxoSmithKline plc., Pfizer, Inc., Clovis Oncology Inc., AbbVie Inc., Bristol - Myers Squibb, Merck KGaA, Genentech, Inc., Repare Therapeutics Inc., Karyopharm Therapeutics Inc., Ono Pharmaceutical Co., LTD., and Jiangsu Hengrui Medicine Co., Ltd. The market is mostly consolidated with these global players having majority share.

Read More:

https://www.dailyprbulletin.com/dna-repair-drugs-market-connected-with-market-growth/

Comments

Popular posts from this blog

The Notchback Market is Estimated To Witness High Growth Owing To Rising Demand From Emerging Economies

The increasing demand for adhesives and sealants is anticipated to open up the new avenue for Petroleum Resins Market

Global Synthetic Biology Market Analysis: Size and Share